XML 30 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 157,607 $ 95,517 $ 628,398 $ 238,468
General and administrative 20,561 15,030 66,782 43,872
Total operating expenses 178,168 110,547 695,180 282,340
Loss from operations (178,168) (110,547) (695,180) (282,340)
Other income, net 17,805 4,686 36,288 18,757
Loss before (benefit) provision for income taxes (160,363) (105,861) (658,892) (263,583)
(Benefit) provision for income taxes (59) (3,287) 687 (171)
Net loss $ (160,304) $ (102,574) $ (659,579) $ (263,412)
Net loss per share — basic (in dollars per share) $ (1.70) $ (1.50) $ (7.50) $ (3.86)
Net loss per share — diluted (in dollars per share) $ (1.70) $ (1.50) $ (7.50) $ (3.86)
Weighted average common shares outstanding—basic (in shares) 94,372,159 68,320,125 87,936,923 68,258,757
Weighted average common shares outstanding—diluted (in shares) 94,372,159 68,320,125 87,936,923 68,258,757
Net loss $ (160,304) $ (102,574) $ (659,579) $ (263,412)
Other comprehensive income (loss), net of tax 218 138 205 (126)
Comprehensive loss $ (160,086) $ (102,436) $ (659,374) $ (263,538)